FI77645B - Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1a,1b-dihomo-3-oxakarbacyklinderivat. - Google Patents

Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1a,1b-dihomo-3-oxakarbacyklinderivat. Download PDF

Info

Publication number
FI77645B
FI77645B FI832557A FI832557A FI77645B FI 77645 B FI77645 B FI 77645B FI 832557 A FI832557 A FI 832557A FI 832557 A FI832557 A FI 832557A FI 77645 B FI77645 B FI 77645B
Authority
FI
Finland
Prior art keywords
group
dihomo
yloxy
tetrahydropyran
denotes
Prior art date
Application number
FI832557A
Other languages
English (en)
Finnish (fi)
Other versions
FI832557A0 (fi
FI832557A (fi
FI77645C (sv
Inventor
Werner Skuballa
Bernd Raduechel
Michael Harold Town
Helmut Vorbrueggen
Jorge Casals-Stenzel
Geb Mannesmann Gerda Varchmin
Ekkehard Schillinger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI832557A0 publication Critical patent/FI832557A0/fi
Publication of FI832557A publication Critical patent/FI832557A/fi
Publication of FI77645B publication Critical patent/FI77645B/fi
Application granted granted Critical
Publication of FI77645C publication Critical patent/FI77645C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Drawers Of Furniture (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Claims (4)

1. Förfarande för framställning av nya, terapeutiskt användbara la,lb-dihomo-3-oxakarbacyklinderivat med den 5 allmänna formeln I 0 (p2) 3-c-°h CfH2
10 CX /V
15. A-W-D-E-R. ÖH 4 väri X är en väteatom eller fluoratom, A är en trans-CH=CH- eller -CsC-grupp,
20 W är en hydroximetylengrupp, varvid OH-gruppen kan befinna sig i oi, - eller β -ställning, D är gruppen -C-CH-, -CH (CH,)-CH.,- eller -C (CH.,), ö E är -CsC-gruppen eller -CH=CH(CH3)-gruppen, och 25 är en alkylgrupp med 1-7 C-atomer, och deras salter med fysiologiskt fördragbara baser, k ä n -netecknat därav, att man pä i och för sig känt sätt och i närvaro av en bas företrar en förening med den allmänna formeln II 30 CH-OH I 2 cx V A-W-D-E-R. 4 OH II II
FI832557A 1982-07-13 1983-07-13 Förfarande för framställning av nya, terapeutiskt användbara 1a,1b-dih omo-3-oxakarbacyklinderivat. FI77645C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3226550 1982-07-13
DE19823226550 DE3226550A1 (de) 1982-07-13 1982-07-13 Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (4)

Publication Number Publication Date
FI832557A0 FI832557A0 (fi) 1983-07-13
FI832557A FI832557A (fi) 1984-01-14
FI77645B true FI77645B (fi) 1988-12-30
FI77645C FI77645C (sv) 1989-04-10

Family

ID=6168531

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832557A FI77645C (sv) 1982-07-13 1983-07-13 Förfarande för framställning av nya, terapeutiskt användbara 1a,1b-dih omo-3-oxakarbacyklinderivat.

Country Status (19)

Country Link
EP (1) EP0099538B1 (sv)
JP (1) JPS5921636A (sv)
AT (1) ATE67182T1 (sv)
AU (1) AU571841B2 (sv)
CA (1) CA1248525A (sv)
CS (1) CS235329B2 (sv)
DD (1) DD210027B3 (sv)
DE (2) DE3226550A1 (sv)
DK (1) DK163579C (sv)
ES (1) ES524058A0 (sv)
FI (1) FI77645C (sv)
GR (1) GR78873B (sv)
HU (1) HU191057B (sv)
IE (1) IE57233B1 (sv)
IL (1) IL69199A (sv)
NZ (1) NZ204875A (sv)
PH (1) PH25119A (sv)
SU (1) SU1316555A3 (sv)
ZA (1) ZA835109B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225288A1 (de) * 1982-07-02 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3225287A1 (de) * 1982-07-02 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacyclinamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS59141536A (ja) * 1983-02-01 1984-08-14 Sumitomo Chem Co Ltd 新規ビシクロオクタン誘導体
DE3405181A1 (de) * 1984-02-10 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4971987A (en) * 1984-07-27 1990-11-20 Schering Aktiengesellschaft New carbacycline, process for their production and their use as a drug
DE3933523A1 (de) * 1989-10-05 1991-04-11 Schering Ag Antimetastatisch wirkende mittel
EP0431571A3 (en) * 1989-12-05 1992-01-02 Sagami Chemical Research Center Cis-bicyclo(4.3.0)non-2-ene derivatives
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
EP1201235B1 (en) * 1999-08-05 2005-10-12 Teijin Limited Neuropathy improvers containing nitrogenous compounds as the active ingredient
EP2094273B1 (en) 2006-11-16 2013-03-06 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza A viral infection
JP2013508282A (ja) 2009-10-14 2013-03-07 ジェンムス ファーマ インコーポレイティド ウイルス感染のための併用療法処置
EP3884935B1 (en) 2013-08-09 2023-06-14 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2038333B (en) * 1978-01-26 1982-10-06 Erba Farmitalia 12 -formyl- (20 12)octanor-9-deoxy-9 -methylene pgi derivatives
US4705806A (en) * 1978-02-13 1987-11-10 Morton Jr Douglas R Prostacyclin analogs
DE3048906A1 (de) * 1980-12-19 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IE54303B1 (en) * 1981-08-19 1989-08-16 Merrell Dow France Fluorinated diaminoalkene derivatives
GR77976B (sv) * 1982-03-12 1984-09-25 Schering Ag
DE3225287A1 (de) * 1982-07-02 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacyclinamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
IL69199A0 (en) 1983-11-30
CA1248525A (en) 1989-01-10
DD210027A5 (de) 1984-05-30
IE57233B1 (en) 1992-06-17
SU1316555A3 (ru) 1987-06-07
DD210027B3 (de) 1990-07-18
GR78873B (sv) 1984-10-02
NZ204875A (en) 1986-11-12
CS235329B2 (en) 1985-05-15
DE3226550A1 (de) 1984-01-19
EP0099538B1 (de) 1991-09-11
PH25119A (en) 1991-02-19
DK163579B (da) 1992-03-16
DK163579C (da) 1992-08-03
JPH0324457B2 (sv) 1991-04-03
AU571841B2 (en) 1988-04-28
IE831630L (en) 1984-01-13
DK321283D0 (da) 1983-07-12
ES8403865A1 (es) 1984-04-16
ZA835109B (en) 1984-08-29
FI832557A0 (fi) 1983-07-13
EP0099538A1 (de) 1984-02-01
FI832557A (fi) 1984-01-14
ATE67182T1 (de) 1991-09-15
HU191057B (en) 1986-12-28
IL69199A (en) 1987-08-31
JPS5921636A (ja) 1984-02-03
ES524058A0 (es) 1984-04-16
DK321283A (da) 1984-01-14
DE3382408D1 (de) 1991-10-17
AU1671883A (en) 1984-01-19
FI77645C (sv) 1989-04-10

Similar Documents

Publication Publication Date Title
FI71122C (fi) Foerfarande foer framstaellning av blodtrycksaenkande och trombosytaggregationshaemmande karbacyklinderivat
FI69056B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara karbacyklinderivat
FI77645B (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1a,1b-dihomo-3-oxakarbacyklinderivat.
FI78065B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara (5e)-13,14,18,18,19,19-hexadehydro-3-oxa-6a- karbaporstaglandin-i2-derivat.
US4497830A (en) Carbacyclins, their preparation and pharmacological use
DK159313B (da) Analogifremgangsmaade til fremstilling af 5-cyanoprostacyklinderivater
NO156524B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive carbacyclinderivater.
FI82040B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara prostacyklinderivat.
FI78064C (sv) Förfarande för framställning av terapeutiskt användbara karbacyklinder ivat
FI77644C (sv) Förfarande för framställning av nya terapeutiskt användbara 3-oxa-5-fl uorkarbacyklinderivat.
CS226440B2 (en) Method of preparing 7-oxoprostacycline derivatives
HU191357B (en) Process for preparing new derivatives of prostaglandin and prostacyclin and pharmaceutical compositions containing such compounds
JPH036145B2 (sv)
HU207715B (en) Process for producing 9-substituted carbacyclin derivatives and pharmaceutical compositions containing them as active components
FI71308B (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara (13e)-(8r,11r,12r)-11,15-dihydroxi-16,19-dimetyl-9-oxo-13,18-prostadiensyraderivat och av deras salter
JPH0510330B2 (sv)

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT